Wave Life Sciences (WVE) Current Deferred Revenue (2014 - 2026)
Wave Life Sciences (WVE) posted Current Deferred Revenue of $8.7 million for Q2 2026, down 83.1% from $51.58 million a year earlier and down 7.4% from the prior quarter.
Wave Life Sciences (WVE) Current Deferred Revenue (2014 - 2026) Analysis & Trends
At the end of FY2025, Wave Life Sciences' Current Deferred Revenue came in at $44.44 million, down 32.6% from FY2024.
- Annual Current Deferred Revenue shows a five-year compound annual growth rate of -13.5% (FY2020 to FY2025).
- In prior years, Wave Life Sciences' Current Deferred Revenue was $65.97 million in FY2024 (-56.0%), $150.06 million in FY2023 (+375.5%), $31.56 million in FY2022 (-14.9%) and $37.1 million in FY2021 (-59.5%).
- The Q2 2026 figure stands as the lowest quarterly Current Deferred Revenue since Q1 2018.
- On a year-over-year basis, Current Deferred Revenue has declined in each of the last seven quarters, with an average decline of 43.0% over the last eight quarters.
- The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q4 2023, with growth of 375.5%; the weakest was Q3 2021, with a decline of 89.9%.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $9.4 million (Q1 2026), $44.44 million (Q4 2025) and $46.53 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Wave Life Sciences | 715.13 Mn | -995.77 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.70 Mn |
| Mar 31, 2026 | 9.40 Mn |
| Dec 31, 2025 | 44.44 Mn |
| Sep 30, 2025 | 46.53 Mn |
| Jun 30, 2025 | 51.58 Mn |
| Mar 31, 2025 | 57.31 Mn |
| Dec 31, 2024 | 65.97 Mn |
| Sep 30, 2024 | 135.91 Mn |
| Jun 30, 2024 | 137.14 Mn |
| Mar 31, 2024 | 140.59 Mn |
| Dec 31, 2023 | 150.06 Mn |
| Sep 30, 2023 | 68.25 Mn |
| Jun 30, 2023 | 111.13 Mn |
| Mar 31, 2023 | 106.96 Mn |
| Dec 31, 2022 | 31.56 Mn |
| Sep 30, 2022 | 32.34 Mn |
| Jun 30, 2022 | 37.47 Mn |
| Mar 31, 2022 | 36.43 Mn |
| Dec 31, 2021 | 37.10 Mn |
| Sep 30, 2021 | 8.74 Mn |
Wave Life Sciences Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=WVE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "WVE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=WVE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();